Evidence map›Paper›PMID 21447380›Full record

ArticleBrain, behavior, and immunity2011

Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains.

Liang Liu, Janet K Coller, Linda R Watkins, Andrew A Somogyi, Mark R Hutchinson

Open access · greenAbstract readComparative Study
In one paragraph

Article in Brain, behavior, and immunity, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 63 citations in OpenAlex.

  1. The neuroimmune-glutamate hypothesis of addiction.Neuroscience and biobehavioral reviews · 2026
    Review
  2. Article
  3. Article
  4. Negative allosteric modulation of CBNeuropharmacology · 2024
    Article
  5. Annual Research Review: Neuroimmune network model of depression: a developmental perspective.Journal of child psychology and psychiatry, and allied disciplines · 2024
    Review
  6. Toll-Like Receptor 4: A Novel Target to Tackle Drug Addiction?Handbook of experimental pharmacology · 2022
    Article
  7. Morphine-3-Glucuronide, Physiology and Behavior.Frontiers in molecular neuroscience · 2022
    Review
  8. Review
  9. Article
  10. Review
  11. Opioid Modulation of the Gut-Brain Axis in Opioid-Associated Comorbidities.Cold Spring Harbor perspectives in medicine · 2021
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. The cannabinoid CBEuropean journal of pharmacology · 2020
    Article
  17. Article
  18. Chronic Morphine-Induced Changes in Signaling at the AThe Journal of pharmacology and experimental therapeutics · 2020
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Liang LiuDiscipline of Pharmacology, School of Medical Sciences, Faculty of Health Sciences, University of Adelaide, Adelaide, South Australia 5005, Australia.
Janet K Coller
Linda R Watkins
Andrew A Somogyi
Mark R Hutchinson
University of Adelaide · AUUniversity of Colorado Boulder · US

Funding

Pain facilitation via neuron-to-glia signalingR01DA017670 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WATKINS, LINDA · 2005 to 2009
$2.0M
Preventing Transition of Acute-to-Chronic Neuropathic Pain: Models, Mechanisms &R01DE021966 · NIDCR · UNIVERSITY OF COLORADO · PI BARTH, DANIEL S., FLESHNER, MONIKA · 2011 to 2015
$2.0M
Exploring the Potential of Glia for Regulating Clinically Relevant Opiod ActionsR01DA023132 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$1.9M
Optoid Analgesics: Modulation of Trigeminal & Spinal Glial ActivationR01DE017782 · NIDCR · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2006 to 2010
$1.9M
Immune and Gilia Regulation of Pain & Analgesic ActionsK05DA024044 · NIDA · UNIVERSITY OF COLORADO · PI WATKINS, LINDA · 2008 to 2012
$616k
Immune/Glial Mediation of Exaggerated Pain StatesK02DA015642 · NIDA · UNIVERSITY OF COLORADO AT BOULDER · PI WATKINS, LINDA · 2003 to 2007
$600k
NIDA NIH HHS DA015642NIDA NIH HHS DA017670NIDA NIH HHS DA024044NIDA NIH HHS K02 DA015642NIDA NIH HHS K05 DA024044NIDA NIH HHS R01 DA017670NIDA NIH HHS R01 DA023132NIDCR NIH HHS DE017782NIDCR NIH HHS R01 DE017782NIDCR NIH HHS R01 DE021966
6 · The paper itself

Abstract

The development of opioid dependence involves classical neuronal opioid receptor activation and is due in part to engagement of glia causing a proinflammatory response. Such opioid-induced glial activation occurs, at least in part, through a non-classical opioid mechanism involving Toll-like-receptor 4 (TLR4). Among the immune factors released following the opioid-glia-TLR4 interaction, interleukin-1β (IL-1β) plays a prominent role. Previous animal behavioral studies have demonstrated significant heterogeneity of chronic morphine-induced tolerance and dependence between different mouse strains. The aim of this study was to investigate whether the heterogeneity of chronic opioid-induced IL-1β expression contributes to differences in opioid tolerance and withdrawal behaviors. Chronic morphine-induced tolerance and dependence were assessed in 3 inbred wild-type mouse strains (Balb/c, CBA, and C57BL/6) and 2 knockout strains (TLR4 and MyD88). Analysis of brain nuclei (medial prefrontal cortex, cortex, brain stem, hippocampus, and midbrain and diencephalon regions combined) revealed that, of inbred wild-type mice, there are significant main effects of morphine treatment on IL-1β expression in the brain regions analyzed (p<0.02 for all regions analyzed). A significant increase in hippocampal IL-1β expression was found in C57BL/6 mice after morphine treatment, whilst, a significant decrease was found in the mPFC region of wild-type Balb/c mice. Furthermore, the results of wild-type inbred strains demonstrated that the elevated hippocampal IL-1β expression is associated with withdrawal jumping behavior. Interestingly, knockout of TLR4, but not MyD88 protected against the development of analgesic tolerance. Gene sequence differences of IL - 1β and TLR4 genes alone did not explain the heterogeneity of dependence behavior between mouse strains. Together, these data further support the involvement of opioid-induced CNS immune signaling in dependence development. Moreover, this study demonstrated the advantages of utilizing multiple mouse strains and indicates that appropriate choice of mouse strains could enhance future research outcomes.

Indexed as

AnimalsBrainCells, CulturedDrug ToleranceHippocampusInflammationInterleukin-1betaLeukocytesLipopolysaccharidesMaleMiceMice, Inbred BALB CMice, Inbred C57BLMice, Inbred CBAMice, KnockoutMorphine DependenceInterleukin-1betaLipopolysaccharidesMyd88 protein, mouseMyeloid Differentiation Factor 88NaloxoneNarcotic AntagonistsTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID21447380
PMCPMC3142610
OpenAlexW1972301631

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.